2024-05-01 | Theravance Biopharma, Inc. TBPH | 10 percent owner | 1.5M 3.0808% | $8.75 | $13.12M | -0.57% | ||
2023-10-20 | Synovus Financial Corp. SNV | 10 percent owner | 560 – | $21.35 | $11,956 | +45.86% | ||
2023-10-13 | Synovus Financial Corp. SNV | 10 percent owner | 4,279 – | $21.50 | $91,999 | +39.81% | ||
2023-10-12 | Synovus Financial Corp. SNV | 10 percent owner | 235 – | $21.50 | $5,053 | +37.73% | ||
2023-10-11 | Synovus Financial Corp. SNV | 10 percent owner | 881 – | $21.50 | $18,942 | +36.21% | ||
2023-10-10 | Synovus Financial Corp. SNV | 10 percent owner | 1,072 – | $21.50 | $23,048 | +35.21% | ||
2023-10-09 | Synovus Financial Corp. SNV | 10 percent owner | 957 – | $21.15 | $20,241 | +39.16% | ||
2023-10-02 | Synovus Financial Corp. SNV | 10 percent owner | 3,466 – | $21.28 | $73,756 | +39.1% | ||
2023-09-27 | Synovus Financial Corp. SNV | 10 percent owner | 12,196 – | $21.30 | $259,775 | +34.57% | ||
2023-09-26 | Synovus Financial Corp. SNV | 10 percent owner | 9,633 – | $21.30 | $205,183 | +34.64% | ||
2023-09-25 | Synovus Financial Corp. SNV | 10 percent owner | 7,553 – | $21.30 | $160,879 | +30.88% | ||
2023-09-22 | Synovus Financial Corp. SNV | 10 percent owner | 9,036 – | $21.30 | $192,467 | +32.66% | ||
2023-09-21 | Synovus Financial Corp. SNV | 10 percent owner | 8,884 – | $21.25 | $188,789 | +33.06% | ||
2023-09-20 | Synovus Financial Corp. SNV | 10 percent owner | 36,425 – | $21.40 | $779,495 | +29.93% | ||
2023-09-19 | Synovus Financial Corp. SNV | 10 percent owner | 197,705 – | $21.40 | $4.23M | +26.24% | ||
2023-03-10 | Stagwell Inc. STGW | director | 750,000 0.6127% | $6.75 | $5.06M | -6.06% | ||
2022-05-10 | Stagwell Inc. STGW | 50,000 0.0401% | $6.90 | $344,790 | +1.32% | |||
2021-12-06 | Stagwell Inc. STGW | director | 290,296 0.3148% | $8.14 | $2.36M | -12.05% | ||
2021-12-03 | Stagwell Inc. STGW | director | 2,665 0.0029% | $7.85 | $20,920 | -8.75% | ||
2021-12-02 | Stagwell Inc. STGW | director | 115,000 0.1264% | $7.73 | $888,950 | -6.17% |